跳至主要内容
临床试验/IRCT2013112915582N1
IRCT2013112915582N1已完成未知

The effects of cholecalciferol, soy isoflavones, and co-administration of them versus placebo on pain, flatulence and quality of life in patients with irritable bowel syndrome

ational Nutrition and Food Technology Institute0 个研究点目标入组 100 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
已完成
发起方
入组人数
100

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 75 years(—)
性别
Female

入选标准

  • age 18-75 yrs; patients with Irritable Bowel Syndrome (IBS) according to ROME III criteria; BMI 18-25; no intestinal organic diseases; no intestinal infection; no history of chronic gastrointestinal and colorectal diseases; no intestinal major surgery; no regular use of antibiotics, anti-constipation and anti-diarrhea, immune suppressors, metocloperamide, cisaperide, difenoxilate, opium and non-steroidal anti-inflammatory drugs; no pregnancy and lactation; not athlete or bed rest; no history of breast cancer in herself or her family; no severe psychosis
  • Exclusion criteria: use of soy isoflavones or vitamin D one year before the study; use of soy milk or soy nuts during study; diet changes during study; use of artificial sweetener 2 days before study; no desire to complete the study; adverse effect of supplement; pregnancy during study

排除标准

  • 未提供

研究者

发起方
ational Nutrition and Food Technology Institute

相似试验